Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients
A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and ...
Sep 18, 2013
0
0